BioSig Technologies, Inc. (NASDAQ:BSGM) reached 88.57% versus a 1-year low price of $3.5. The stock was last seen -3.93% lower, reaching at $6.6 on 5/28/2019. At a recent session, the prices were hovering between $6.41 and $6.8. This company shares are 74.24% off its target price of $11.5 and the current market capitalization stands at $139.39M. The recent change has given its price a -3.53% deficit over SMA 50 and -33.8% deficit over its 52-week high. The stock witnessed -1.49% declines, 19.57% gains and 69.67% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found BSGM’s volatility during a week at 9.01% and during a month it has been found around 7.86%.BioSig Technologies, Inc. (BSGM) Top Holders
Institutional investors currently hold around $7 million or 4.7% in BSGM stock. Look at its top three institutional owners: Vanguard Group Inc owns $1.72 million in BioSig Technologies, Inc., which represents roughly 1.23% of the company’s market cap and approximately 24.56% of the institutional ownership. Similar statistics are true for the second largest owner, Zeke Capital Advisors, Llc, which owns 207,400 shares of the stock are valued at $1.43 million. The third largest holder is Millennium Management Llc, which currently holds $964 thousand worth of this stock and that ownership represents nearly 0.69% of its market capitalization.
At the end of March reporting period, 15 institutional holders increased their position in BioSig Technologies, Inc. (NASDAQ:BSGM) by some 345,677 shares, 8 decreased positions by 64,856 and 6 held positions by 612,404. That puts total institutional holdings at 1,022,937 shares, according to SEC filings. The stock grabbed 8 new institutional investments totaling 222,455 shares while 4 institutional investors sold out their entire positions totaling 43,146 shares.BioSig Technologies, Inc. (NASDAQ:BSGM) Insider Trades
Multiple company employees have indulged in significant insider trading. BioSig Technologies, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that CEO, 10% Owner LONDONER KENNETH L has acquired 10,000 shares of BioSig Technologies, Inc. (BSGM) in the trading session dated May. 24, 2019. These shares are worth $66,700 and were traded at $6.67 each. The SEC filing shows that LONDONER KENNETH L performed a purchase of 6,000 shares. The CEO, 10% Owner added these shares by way of transaction on May. 23, 2019. The company’s shares were assimilated at $6.88 per share worth to an investment of some $41,280 to the account of LONDONER KENNETH L.
CEO, 10% Owner, LONDONER KENNETH L, purchased 9,400 common shares of BioSig Technologies, Inc. (BSGM) in the open market. In a transaction dated May. 21, 2019, the shares were bought at an average price of $7.3, giving away a sum of $68,620. After this purchase, 2,089,567 common shares of BSGM are directly owned by the insider, with total stake valued at $13,791,142.
In the transaction dated May. 20, 2019, a great number of shares acquired came courtesy the CEO, 10% Owner; LONDONER KENNETH L added a total of 15,000 shares at an average price of $7.78, amounting to approximately $116,700. The insider now directly owns 2,080,167 shares worth $13,729,102.
Several analysts have released their opinion on BioSig Technologies, Inc. (NASDAQ:BSGM), with 0 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 3 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2 average brokerage recommendation [T1].